Treatment of osteoporosis: why, whom, when and how to treat

B E Christopher Nordin and Allan G Need
Med J Aust 2004; 181 (5): . || doi: 10.5694/j.1326-5377.2004.tb06282.x
Published online: 6 September 2004

B E Christopher Nordin,* Allan G Need†

  • B E Christopher Nordin2
  • Allan G Need2

  • 1 Endocrine and Metabolic Unit, Royal Adelaide Hospital, Adelaide, SA
  • 2 Division of Clinical Biochemistry, Institute of Medical and Veterinary Science, Adelaide, SA.

Competing interests:

A G N has received research funding from Eli Lilly, Merck Sharpe & Dohme and Roche Products, and travel assistance from Merck Sharp & Dohme.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.